CAS 2417012-26-9

1(2H)-Isoquinolinone, 2-[(S)-cyclopropyl(4-methyl-2-pyridinyl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3,4-dihydro-7-(1H-imidazol-1-ylmethyl)-

Description:

1(2H)-Isoquinolinone, 2-[(S)-cyclopropyl(4-methyl-2-pyridinyl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3,4-dihydro-7-(1H-imidazol-1-ylmethyl)- is a complex organic compound characterized by its multi-cyclic structure, which includes an isoquinolinone core. This compound features various functional groups, including a cyclopropyl moiety, a pyridine ring, a trifluoromethyl group, and an imidazole substituent, contributing to its potential biological activity. The presence of these diverse functional groups suggests that it may exhibit interesting pharmacological properties, possibly acting as a ligand or inhibitor in biochemical pathways. The stereochemistry indicated by the (S) designation suggests chirality, which can influence the compound's interaction with biological targets. Additionally, the trifluoromethyl group is known to enhance lipophilicity and metabolic stability, potentially affecting the compound's pharmacokinetics. Overall, this compound's intricate structure and functional diversity make it a candidate for further investigation in medicinal chemistry and drug development.

Formula: C₂₉H₂₉F₃N₆O

Synonyms:

• WDR5 inhibitor 41
• 1(2H)-Isoquinolinone, 2-[(S)-cyclopropyl(4-methyl-2-pyridinyl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-3,4-dihydro-7-(1H-imidazol-1-ylmethyl)-
• WDR5-IN-5

WDR5-IN-5

CAS: 2417012-26-9

WDR5-IN-5: Selective oral inhibitor for WDR5's WIN site with high affinity (Ki<0.02 nM) and anti-cancer properties. Good pharmacokinetics.

Formula: C₂₉H₂₉F₃N₆O

Color and Shape: Solid

Molecular weight: 534.58

Ref: TM-T63763